Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101602681A details a solvent-free Ni(OAc)2 catalyzed route for beta-enaminones, offering high purity and eco-friendly processing for pharmaceutical intermediates.
Patent CN112079803A details high-purity 4-halophthalic anhydride synthesis. Offers supply chain reliability and cost advantages for global pharmaceutical and flame retardant manufacturers.
Patent CN116102610B reveals one-pot steroid synthesis reducing waste. Offers cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN102617312B reveals a greener synthesis route for 2-chloro-6-fluorobenzaldehyde using ferric solid superacid, offering significant cost reduction and higher purity for API intermediates.
Patent CN112142750B reveals a green one-pot synthesis for triazolo pyrimidine derivatives using acidic ionic liquids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN116003369A reveals a novel Sc(OTf)3-catalyzed hydrogen migration strategy for efficient spirochroman synthesis, offering significant cost and supply chain advantages for pharmaceutical intermediate manufacturing.
Novel boric acid-catalyzed route for 1,4-dialkoxy anthracene ensures high yield and safety. Ideal for anti-counterfeiting and optical applications.
Patent CN102993253B reveals a reusable polymer-supported catalyst method for synthesizing capecitabine intermediates, offering significant supply chain stability and cost reduction in pharmaceutical manufacturing.
Novel HF/BF3 catalyzed formylation process offers high regioselectivity and yield for perfume intermediates, ensuring supply chain stability.
Patent CN105111179A details a green ionic liquid method for high-purity benzo[g]chromene derivatives, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN103122012B reveals a streamlined synthesis for fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102558127B details a green microwave-assisted route for high-purity polyhydroxy flavones, offering significant cost reduction and scalability for pharmaceutical manufacturers.
Patent CN107501156B details a one-pot synthesis for 2-cyano-3-arylpyrroles. This method offers significant cost reduction in API manufacturing and high-purity intermediates.
Patent CN106588612A details ionic liquid catalysis for 5-chloro-1-indanone. Achieve high purity and cost reduction in agrochemical intermediate manufacturing with scalable solutions.
Novel metal-free synthesis of naphthofurans offers significant cost reduction and enhanced supply reliability for pharmaceutical intermediate manufacturing partners seeking high purity materials globally.
Patent CN108503573B details a high-purity Brivaracetam route eliminating chiral separation. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Novel one-pot Ferrier rearrangement using FeCl3 catalyst. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN100564362C reveals a streamlined Lewis acid catalyzed route for Azoxystrobin, offering significant cost reduction and supply chain reliability for global agrochemical manufacturers.
Patent CN113831340B reveals a novel Lewis acid-catalyzed route for calix[n]dihydroacridine macrocycles, offering high yields and simplified purification for electronic chemical manufacturing.
Patent CN104326987B reveals water-phase catalytic synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.